Female
Multidisciplinary Team(s)
Hematologic (Malignant)
Department/Research Program(s)
Department of Oncology
Cancer Type(s)
Hodgkin's Lymphoma
Leukemia
Lymphoma
Multiple Myeloma
Myelodysplasia (MDS)
Non-Hodgkin's Lymphoma
Plasmacytoma
Contact Info
Email:
m.runge-morris@wayne.edu
Education
Fellowship
Fellowship Hematology-Oncology, Northwestern University, Chicago, IL
Fellowship
Postdoctoral Fellow, NIH Physician Scientist Award, Dept. of Pharmacology, Northwestern University
Medical School
University of MIchigan
1979
Residency
Internal Medicine, Hennepin County Hospital, Minneapolis, Minnesota
Graduate Training
University of MIchigan
Professional Memberships/Associations
International Society for the Study of Xenobiotics (ISSX)
American Association for Cancer Research (AACR)
American Society for Biochemistry and Molecular Biology (ASBMB)
American Society of Clinical oncology (ASCO)
American Society of Hematology (ASH)
American Society for Pharmacology and Experimental Therapeutics (ASPET)
Board Certifications
American Board of Internal Medicine
Medical Oncology
Clinical Interests
Medical Oncology
Research Interests
NIH-funded research program focused on the molecular regulation of sulfotransferase gene expression: implications for toxicity
Awards
2006Wayne State University School of Medicine, Faculty Research Excellence Award
2004Wayne State University School of Medicine, College Teaching Award
Physician Scientist Training Award, National Institutes of Environmental Health Sciences Grant Number: K11 - ES 00170
National Institute of Health Neuroscience Toxicology Fellowship, National Institutes of Health Training Grant T32 NS07140, Department of Pharmacology, Northwestern University
Publications
The Kinetics of Sterol Sulfonation by Sulfotransferases: Implications for Nuclear Receptor Activation, in preparation. Authors: I. Cook, Z. Duniec-Dmuchowski, T.A. Kocarek, M. Runge-Morris and C.N. Falany (2012).
Site-Directed Mutagenesis of Human Cytosolic Sulfotransferase (SULT)2B1b to Phospho-Mimetic Ser348Asp Results in an Isoform with Increased Catalytic Activity. J. Steroid Biochem. Mol. Bio., 127: 315-323. Authors: E.D. Salman, D. He, M. Runge-Morris, T.A. Kocarek, and C.N. Falany (2011)
Regulation of SULT1E1 expression by Confluency of MCF10A Breast Epithelial Cells: Role of the Aryl Hydrocarbon Receptor. J. Pharmacol. Exp. Ther., 339: 597-606. Authors: J. Fu, H. Fang, M. Paulsen, M. Ljungman, T.A. Kocarek and M. Runge-Morris (2011)
Sulfation of 25-Hydroxycholesterol by SULT2B1b Decreases Cellular Lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells. Atherosclerosis 214: 350-356. Authors: Q. Bai, L. Xu, L., G. Kakiyama, M.A. Runge-Morris, P.B. Hylemon, L. Yin, W.M. Pandak, and S. Ren, (2011)
expression of Estrogenicity Genes in a Lineage Cell Culture Model of Human Breast Cancer Progression. Breast Cancer Res. Treat., 120: 35-45. Authors: J. Fu, A.M. Weise, J. L. Falany, C.N. Falany, B.J. Thibodeau, F.R.Miller, T.A. Kocarek and M. Runge-Morris (2010)
